Department of Internal Medicine, Uwajima City Hospital, Uwajima, Ehime 798-8510, Japan.
Endocr J. 2013;60(4):449-55. Epub 2012 Dec 19.
We previously reported that serum interleukin-18 (IL-18) levels were significantly increased in hyperthyroid Graves' disease patients. The development of insulin resistance in hyperthyroidism has been documented. We investigated the relationship between IL-18 and insulin resistance in patients with hyperthyroid Graves' disease and in experimental hyperthyroid mice. Then, we examined whether IL-18 induces insulin resistance in mice injected with IL-18 for a week. A significant positive correlation was observed between serum IL-18 levels and parameters such as thyroid functions and homeostasis model assessment for insulin resistance in hyperthyroid Graves' disease. In experimental hyperthyroid mice, IL-18 was significantly elevated. Insulin resistance increased in experimental hyperthyroid mice and IL-18-injected mice. These findings suggest IL-18 to be an important factor inducing insulin resistance in hyperthyroidism.
我们之前曾报道过,甲状腺功能亢进症格雷夫斯病患者的血清白细胞介素-18(IL-18)水平显著升高。已经有文献证明甲状腺功能亢进症中存在胰岛素抵抗的发生。我们研究了甲状腺功能亢进症格雷夫斯病患者和实验性甲状腺功能亢进症小鼠中 IL-18 与胰岛素抵抗之间的关系,并进一步检测了 IL-18 是否会导致注射 IL-18 一周的小鼠出现胰岛素抵抗。在甲状腺功能亢进症格雷夫斯病患者中,血清 IL-18 水平与甲状腺功能和胰岛素抵抗的稳态模型评估等参数之间存在显著正相关。在实验性甲状腺功能亢进症小鼠中,IL-18 水平显著升高。实验性甲状腺功能亢进症小鼠和注射 IL-18 的小鼠中胰岛素抵抗增加。这些发现表明 IL-18 是导致甲状腺功能亢进症中胰岛素抵抗的一个重要因素。